BioMerieux: Remains an attractive investment and top choice in the testing sector

Published on 24/04/2025 at 15:47 - Modified on 24/04/2025 at 16:22

Alphavalue

This Alphavalue article, the European leader in independent research, is only available to subscribers .

Alphavalue is exclusively on MarketScreener.
To unlock the article, SUBSCRIBE!

Already a customer? Log In

Latest news about bioMérieux

AlphaValue/Baader Europe Ups BioMérieux Price Target	07-15	MT
BIOMÉRIEUX : AlphaValue raises target price	07-14
BIOMERIEUX : Attractiveness reinforced	07-11
BioMérieux S.A. acquired Key Assets of Day Zero Diagnostics Inc.	06-16	CI
BioMérieux: agreement to acquire Day Zero Diagnostic	06-16
Biomerieux Acquires Day Zero Diagnostics Solutions And Technologies	06-16	RE
BioMérieux S.A. Launches Equine Infectious Respiratory Disease Testing with VETFIRE	06-03	CI
BioMérieux: launches a test for respiratory diseases	06-03
GXO Logistics, Inc. Extends Long-Term Contract Renewal and Extension with BioMerieux	05-22	CI
RBC Capital Downgrades bioMérieux to Sector Perform, Trims PT	05-07	MT
BIOMÉRIEUX : RBC downgrades stock	05-07
BioMérieux: stock falls after RBC's downgrade	05-07
The stock market returns to "Risk On"	04-25
BIOMERIEUX : Remains an attractive investment and top choice in the testing sector	04-24
BIOMÉRIEUX : Invest Securities remains positive, cuts TP	04-22
BioMérieux: launches test for wastewater	04-22
European shares clock marginal losses after ECB eases rates as expected	04-17	RE
BIOMERIEUX : Despite a better-than-expected Q1, investors expressed disappointment with tariffs	04-17
BioMerieux Shares Fall After Warning on Currency-Exchange Hit	04-17	DJ
European shares clock marginal losses after ECB eases rates as expected	04-17	RE
BioMérieux: quarterly revenue up over 13%	04-17
Biomerieux Q1 Total Sales EUR 1.10 Billion	04-17	RE
TP ICAP Midcap Downgrades bioMérieux to Hold, Lowers PT	04-07	MT
BioMérieux's Lumed Apss Software System Wins CE Marking	04-07	MT
Biomerieux Obtains CE-Marking For LUMED APSS	04-07	RE